Torrent Pharma enters OTC market

15 Feb 2023 , 09:45 AM

Torrent Pharmaceuticals announced it has entered the over-the-counter market with Shelcal 500, a calcium supplement brand. Shelcal 500, which contains 500mg of calcium and 250 IU of Vitamin D3, aids in calcium absorption, improves muscle strength, increases bone density, and boosts immunity.

Calcium is derived from natural ingredients such as oyster shells and has high absorption/ bioavailability in the body.

In a statement, Aman Mehta, Director of Torrent Pharmaceuticals, expressed that Shelcal’s introduction to the OTC market sets the stage for the brand to claim the top spot as the leading calcium supplement brand in India.

Torrent Pharmaceuticals has a diverse portfolio of products ranging from the cardiovascular, central nervous system, gastrointestinal, anti-infective, and oncology to pain management, and many others. The company has a robust research and development division and has invested heavily in developing innovative formulations and novel drug delivery systems.

At around 9.43 AM, Torrent Pharma was trading at Rs1,490 per piece, down by 1.52% against the previous close of Rs1,512.95 on NSE.

For feedback and suggestions, write to us at [e-mail]